Navigation Links
SyntheMed Announces New Management Appointments
Date:10/2/2008

ISELIN, N.J., Oct. 2 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced today that Richard L. Franklin, MD, the company's Chairman, has assumed the newly-created position of Executive Chairman and Gere S. diZerega, MD, one of the company's clinical advisors, has assumed the newly-created position of Medical Director. In these consultancy roles, Dr. Franklin will be primarily involved with strategic planning, external communications and Board leadership whereas Dr. diZerega will focus on clinical and regulatory strategy and product planning. Robert P. Hickey, the company's President & CEO stated, "We are very fortunate that Rick and Gere have agreed to expand their involvement with our company and we look forward to benefiting from their experience and expertise."

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products and other surgical implants based on its proprietary bioresorbable polymer technology. The company is developing a portfolio of anti-adhesion products lead by REPEL-CV(R) Adhesion Barrier, an anti-adhesion product intended for use in open heart surgical procedures. REPEL-CV is currently marketed internationally and is awaiting FDA approval to market in the United States.

Statements in this press release that are not statements of historical fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include but are not limited to (i) potential adverse developments regarding the company's efforts t
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SyntheMed Completes $4.0 Million Equity Placement
2. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
3. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
4. SyntheMed Files Universal Shelf Registration
5. SyntheMed to Present at the Acumen BioFin Conference
6. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
7. Alba Therapeutics Corporation Announces Promotions
8. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
9. 23andMe Announces Breast Cancer Initiative
10. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
11. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , DURHAM, N.C., Nov. 25 /PRNewswire/...led the first energy-efficient, single-treatment w...om carbon nanotubes to Andhra Pradesh, Minister of...her leaders in Hyderabad, India today. Initial tes...IT) Kanpur, confirmed that the majority of the dri...
(Date:11/25/2009)... Ambassador to Speak at Eco...ronto, Canada (Vocus) November 25, 2009 -- Ambassa...Who: ,David Appia, French Ambassador for Internati...t in France Agency ,To view a biography of David A...Ambassador Appia is available to meet with press t...
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...rch report is available in its catalogue: ,, B...2013 ,, http://www.reportlinker.com/p0165503/...-2013.html ,, Brazil Bioethanol Market Analysi...report provides detailed analysis and forecasts of...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...., Feb. 20 InterMune, Inc. (Nasdaq: ITMN ) anno...d full-year 2008 financial results on Thursday, Fe... conference call and webcast will be hosted by Int... , To access the live teleconference, dial 888-79...ference ID# 86755415. To access the webcast, plea...
...The Netherlands, February 20 Nyenrode Business,Un...to Professor Michael,Porter, icon in the field of ...heory. Professor Porter is generally considered as...e world,s most influential thought leader in the,f...ssor Porter will receive,the Honorary Doctorate on...
...fety Study in Patients with Severe Post-Operative ...its and Support NDA Submission , , SYDNEY and BED...X and OTCQX: QRXPY), a clinical-stage specialty ph...d commercialisation of therapies for pain and cent...y the initiation of a comparative 3-arm pilot stud...
Other Biology Technology:InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26 2Nyenrode Honorary Doctorate for Professor Michael E. Porter 2QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy 2QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy 3QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy 4
(Date:11/30/2009)...a colorless and odorless radioactive gas that is p... is a product of uranium decay and is found in tra...nd groundwater as well as building materials, plan...tration is expressed as the amount of radiation th...s in a liter of air; thus the units are picocuries...
(Date:11/26/2009)...have at last worked out a way of using recordings ... populations. This is the first time sound recordi...nto accurate estimates of bird species, population...ish Ecological Society,s Journal of Applied Ecolo... to a major advance in our ability to monitor whal...
(Date:11/26/2009)...erg, 27 November 2009 What are the bare essential...to produce a cell that can survive on its own? Can...understand how an entire organism functions as a s...cientists in a partnership between the European Mo...ermany, and the Centre de Regulacio Genmica (CRG) ...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 1New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 2New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 4New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 5Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009 13979 1Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009 13979 2Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 1Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 2Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 3Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 4Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 5
...are the first to create a large-scale, cell-based ...ctivate immune-response cells that hold promise fo...ning technique can scan thousands and even million...dritic cells, which are on constant recon patrol t...ted cells and alert the immune system. , "Our ass...
...itoes that helps the insects to fight off infectio... in humans. Anopheles mosquitoes transmit the mala...e each year with these cases resulting in more tha...as identified in a study conducted by a team of in...l of Public Health,s Malaria Research Institute, t...
...ia, private practice, government and industry are ... symposium in interventional oncology, a rapidly g...ve interventional radiology treatments for cancer....tments for liver, kidney, bone and lung tumors. Th...ty for cross-fertilization between researchers in ...
Other Biology News:UT Southwestern researchers develop screening test for cells that activate immune system 2Gene that helps mosquitoes fight off malaria parasite identified 2Minimally Invasive Cancer Treatments Highlighted 2Minimally Invasive Cancer Treatments Highlighted 3
Mouse Anti-HIV-Imn PND Antibody, Unconjugated from Raybiotech, Inc.
... Product Goat polyclonal to BRF2 Immunogen Synt...terminal amino acids 406-419 of Human BRF2. React...yet tested in other species. Background Informati...A polymerase III transcription factor complex requ...
Kinase Buffer (10X) from Cell Signaling Technology
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: